P3LAB
formerly neuroCluesThe brain's stethoscope
P3LAB was founded in 2020, is headquartered in Louvain-la-Neuve, Belgium, lists 11–50 employees, and has $17.4M in recorded funding across 2 rounds.
- Headquarters
- Louvain-la-Neuve, Walloon Region
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- neuroclues.com
- Total Funding
- $17.4M
- Last Round
- $11.6M Series AApr 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
P3Lab is a European MedTech company that develops NeuroClues, a portable eye-tracking medical device and platform that records and analyzes eye movements to provide objective, quantified biomarkers for the earlier detection of neurological disorders including Parkinson's disease, Alzheimer's disease, and multiple sclerosis. Founded in 2020 by Antoine Pouppez, Pierre Daye, and Pierre Pouget — former ICM and IBA researchers — the company's CE-marked platform delivers clinically validated assessments in minutes at the point of care, enabling neurologists to identify disease years before visible symptoms appear. In April 2026, the company raised a EUR 10M Series A to accelerate rollout across Europe and prepare for U.S. market entry.
Summary
P3LAB is a Biotech company based in Louvain-la-Neuve, Belgium, founded in 2020. It lists 11–50 employees. It has raised $17.4M in total across 2 rounds, most recently a $11.6M Series A round in Apr 2026. Investors include White Capital and European Innovation Council Fund.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2026
Sign up to see all 2 events
Funding: Venture Round through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/p3lab"><img src="https://indexed.vc/api/badge/company/p3lab" alt="P3LAB on Indexed.vc" width="260" height="76" /></a>